The role of mylohyoid flap in the treatment of bisphosphonate-related osteonecrosis of the jaws

Thomas Mücke, Steffen Koerdt, Maximilian Jung, David A. Mitchell, Klaus Dietrich Wolff, Marco Rainer Kesting, Denys John Loeffelbein

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

Introduction Surgical treatment of bisphosphonate-related osteonecrosis of the jaws (BRONJ) combines excision of adequate damaged bone and watertight coverage by appropriate vascularized tissue. Local tissues are preferred when possible. This study compares local mucoperiosteal flaps with mylohyoid flaps with special emphasis on their influence on wound healing. Material and methods A total of 195 patients with BRONJ in the mandible were included in this prospective study. The control group (n = 169) were treated with a mucoperiosteal flap, whereas patients of the study group (n = 26) received a mylohyoid flap. Results Recurrence of BRONJ was significantly reduced (p = 0.023) as was extent of necrosis (p = 0.001) in patients with mylohyoid flaps. Discussion This study demonstrates the importance of a sufficient mucosal coverage in surgical treatment of BRONJ. The mylohyoid flap provides an additional tissue coverage, which seems to account for the significantly reduced rate of disease recurrence. Conclusion The vascularized mylohyoid flap is an important tool in the complex and challenging surgical care of BRONJ.

Original languageEnglish
Pages (from-to)369-373
Number of pages5
JournalJournal of Cranio-Maxillofacial Surgery
Volume44
Issue number4
DOIs
StatePublished - 1 Apr 2016

Keywords

  • Bisphosphonates
  • Jaws
  • Microvascular free flap
  • Osteonecrosis
  • Recurrence
  • Treatment outcome

Fingerprint

Dive into the research topics of 'The role of mylohyoid flap in the treatment of bisphosphonate-related osteonecrosis of the jaws'. Together they form a unique fingerprint.

Cite this